37 related articles for article (PubMed ID: 1380822)
1. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
[TBL] [Abstract][Full Text] [Related]
2. MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study.
Lameira AG; Pontes FS; Guimarães DM; Alves AC; de Jesus AS; Pontes HA; Pinto Ddos S
J Oral Pathol Med; 2014 Jul; 43(6):427-34. PubMed ID: 24456424
[TBL] [Abstract][Full Text] [Related]
3. [Expression of Ki-67 and P53 protein in oral squamous cell carcinoma and its clinical significance].
He W; Xiao Y; Chen WM
Shanghai Kou Qiang Yi Xue; 2015 Apr; 24(2):228-31. PubMed ID: 25938156
[TBL] [Abstract][Full Text] [Related]
4. p53, Cyclin D1, p21 (WAF1) and Ki-67 (MIB1) Expression at Invasive Tumour Fronts of Oral Squamous Cell Carcinomas and Development of Local Recurrence.
Sawair F; Hassona Y; Irwin C; Stephenson M; Hamilton P; Maxwell P; Gordon D; Leonard A; Napier S
Asian Pac J Cancer Prev; 2016; 17(3):1243-9. PubMed ID: 27039754
[TBL] [Abstract][Full Text] [Related]
5. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K
APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760
[TBL] [Abstract][Full Text] [Related]
6. p53 expression and p53 gene mutation in oral cancer and dysplasia.
Rowley H; Sherrington P; Helliwell TR; Kinsella A; Jones AS
Otolaryngol Head Neck Surg; 1998 Jan; 118(1):115-23. PubMed ID: 9450841
[TBL] [Abstract][Full Text] [Related]
7. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of immuno-histochemical markers in oral squamous cell carcinoma.
Guruprasad Y; Singhal P; Gupta N; Kukreja BJ; Gupta B; Kukreja P; Makkad RS; Mehta DN
Bioinformation; 2023; 19(13):1399-1404. PubMed ID: 38415034
[TBL] [Abstract][Full Text] [Related]
9. p53, p63 and p73 expression and angiogenesis in keratocystic odontogenic tumors.
Chandrangsu S; Sappayatosok K
J Clin Exp Dent; 2016 Dec; 8(5):e505-e511. PubMed ID: 27957261
[TBL] [Abstract][Full Text] [Related]
10. Histopathological correlation of oral squamous cell carcinoma among younger and older patients.
Ur Rahaman SM; Ahmed Mujib B
J Oral Maxillofac Pathol; 2014 May; 18(2):183-8. PubMed ID: 25328296
[TBL] [Abstract][Full Text] [Related]
11. Genes and oral cancer.
Jurel SK; Gupta DS; Singh RD; Singh M; Srivastava S
Indian J Hum Genet; 2014 Jan; 20(1):4-9. PubMed ID: 24959008
[TBL] [Abstract][Full Text] [Related]
12. Expression of p53 protein and ki-67 antigen in oral premalignant lesions and oral squamous cell carcinomas: An immunohistochemical study.
Humayun S; Prasad VR
Natl J Maxillofac Surg; 2011 Jan; 2(1):38-46. PubMed ID: 22442608
[TBL] [Abstract][Full Text] [Related]
13. Molecular pathogenesis of oral squamous carcinoma.
Williams HK
Mol Pathol; 2000 Aug; 53(4):165-72. PubMed ID: 11040937
[TBL] [Abstract][Full Text] [Related]
14. Nuclear DNA content and p53 overexpression in stage I squamous cell carcinoma of the tongue compared with advanced tongue carcinomas.
Högmo A; Kuylenstierna R; Lindholm J; Nathansson A; Auer G; Munck-Wikland E
Mol Pathol; 1998 Oct; 51(5):268-72. PubMed ID: 10193521
[TBL] [Abstract][Full Text] [Related]
15. In vivo infiltration of mononuclear cells in squamous cell carcinoma of the head and neck correlates with the ability to expand tumour-infiltrating T cells in vitro and with the expression of MHC class I antigens on tumour cells.
Hald J; Rasmussen N; Claesson MH
Cancer Immunol Immunother; 1994 Dec; 39(6):383-90. PubMed ID: 8001026
[TBL] [Abstract][Full Text] [Related]
16. The role of oncogenes and tumour-suppressor genes in the aetiology of oral, head and neck squamous cell carcinoma.
Field JK
J R Soc Med; 1995 Jan; 88(1):35P-39P. PubMed ID: 7884768
[No Abstract] [Full Text] [Related]
17. p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck.
Nylander K; Nilsson P; Mehle C; Roos G
Br J Cancer; 1995 Apr; 71(4):826-30. PubMed ID: 7710950
[TBL] [Abstract][Full Text] [Related]
18. Expression of the tumour suppressor gene p53 in oral cancer.
Langdon JD; Partridge M
Br J Oral Maxillofac Surg; 1992 Aug; 30(4):214-20. PubMed ID: 1380822
[TBL] [Abstract][Full Text] [Related]
19. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Girod SC; Pfeiffer P; Ries J; Pape HD
Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
